~~<i id='1383AC7150'><strike id='1383AC7150'><tt id='1383AC7150'><pre id='1383AC7150'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：Wikipedia 2025-08-04 06:02:09 - browse：3546

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： First transplant of an entire human eye performed

leisure time

knowledge

hotspot

knowledge

hotspot

leisure time

AhelicopterfliesaboveHoustonaweekafterHurricaneHarveyfloodedthearea.JustinSullivan/GettyImagesInlate

WSS

Donald Trump's relentless attacks on special counsel Jack Smith

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Ask STAT: What do you want to know about ChatGPT in medicine?

Why we need to separate burnout from moral injury in health care

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

The science behind Janet Jackson's pregnancy at 49

knowledge

Wikipedia

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Do masks work? RCTs can't tell us

As demand for Covid shots wanes, Moderna seeks its next success

Disclosing genetic information: not as worrisome as once feared

ChatGPT in medicine: STAT answers readers' burning questions

NIH chief: government has fallen behind pharma on clinical trials

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cloning humans is technically possible. It's curious no one has tried

Tori Bowie and the unacceptable rates of Black maternal death

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

knowledge

White House drug czar issues call for 'recovery

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Type 2 diabetes prevention programs work at large scale: study

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Do masks work? RCTs can't tell us

Why are elite athletes different? Take a look at their microbes

hotspot

knowledge

hotspot

leisure time